|
Co-development of new pharmaceutical formulations |
|
|
|
|
The more and more challenging market conditions and the dynamic of
the ethical and generic pharmaceutical formulations, on one hand, and
the implications of the globalization and numerous mergers and
acquisitions during the past years are increasing competition in this
field.
Co-development of pharmaceutical products together with
a professional regulatory organization and by having an exclusive
agreement with a GMP certified API manufacturer gives to a
pharmaceutical manufacturer the opportunity to secure its business on
long term, in a cost-effective and timely manner.
|
